Effects of Repeated Doses of Intravenous Immunoglobulin in Myasthenia Gravis

Grob, 1961, Myasthenia gravis. A review of pathogenesis and. treatment, Arch Intern Med, 108, 615, 10.1001/archinte.1961.03620100107017 Patrick, 1973, Autoimmune response to acetylcholine receptor, Science, 180, 871, 10.1126/science.180.4088.871 Grob, 1981, The natural course of myasthenia gravis and effect of therapeutic measures, Ann NY Acad Sci, 377, 652, 10.1111/j.1749-6632.1981.tb33764.x Rowland, 1956, Fatalities in myasthenia gravis, Neurology, 6, 302, 10.1212/WNL.6.5.307 Randall, 1955, Pharmacology of anticholinesterase drugs, mestinon, prostigmin, tensilon and TEEP, Am J Med, 102, 673, 10.1016/S0002-9343(55)80006-X Arsura, 1987, Adverse cardiovascular effects of anticholinesterase medications, Am J Med Sci, 293, 18, 10.1097/00000441-198701000-00005 Brunner, 1972, Corticosteroids in management of severe, generalized myasthenia gravis, Neurology, 22, 603, 10.1212/WNL.22.6.603 Brunner, 1976, Corticotropin and corticosteroids in generalized myasthenia gravis: comparative studies and role in management, Ann NY Acad Sci, 274, 577, 10.1111/j.1749-6632.1976.tb47717.x Arsura, 1985, High-dose intravenous methylprednisolone in myasthenia gravis, Arch Neurol, 42, 1149, 10.1001/archneur.1985.04060110031011 Haynes, 1980, Adrenocorticotropic hormone; adrenocortical Steroid and their synthetic analogs; inhibitors of adrenocortical Steroid biosynthesis, 1466 Cohen, 1981, Aspects of the natural history of myasthenia gravis. Crisis and death, Ann NY Acad Sci, 377, 670, 10.1111/j.1749-6632.1981.tb33765.x Dau, 1977, Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis, N Engl J Med, 297, 1134, 10.1056/NEJM197711242972102 Olarte, 1981, Effects of plasmapheresis in myasthenia gravis 1978-1980, Ann NY Acad Sci, 377, 725, 10.1111/j.1749-6632.1981.tb33770.x Kornfeld, 1979, Plasmapheresis in myasthenia gravis: controlled study, Lancet, 2, 629, 10.1016/S0140-6736(79)91680-5 Newsom-Davis, 1979, Long-term effects of repeated plasma exchange in myasthenia gravis, Lancet, i, 464, 10.1016/S0140-6736(79)90823-7 Mertens, 1981, Effect of immunosuppressive drugs (azathioprine), Ann NY Acad Sci, 377, 691, 10.1111/j.1749-6632.1981.tb33767.x Howard, 1982, Nonsteroidal immunosuppressive therapy for myasthenia gravis, Seminars in Neurology, 2, 265, 10.1055/s-2008-1041654 Papatestas, 1976, Thymectomy in myasthenia gravis: pathologic, clinical and electrophysiologic correlations, Ann NY Acad Sci, 274, 555, 10.1111/j.1749-6632.1976.tb47715.x Imbach, 1981, High-dose intravenous gamma globulin per idiopathic thrombocytopenic purpura in childhood, Lancet, i, 1228, 10.1016/S0140-6736(81)92400-4 Fehr, 1982, Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by highdose intravenous gamma globulin, N Engl J Med, 306, 1254, 10.1056/NEJM198205273062102 Poliack, 1982, High-dose intravenous gamma globulin for autoimmune neutropenia, N Engl J Med, 307, 253, 10.1056/NEJM198207223070420 Sultan, 1984, Antiidiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gamma globulin, Lancet, ii, 765, 10.1016/S0140-6736(84)90701-3 Furusho, 1984, High-dose intravenous gamma globulin for Kawasaki disease, Lancet ii, 1055, 10.1016/S0140-6736(84)91504-6 Godard, 1985, Bullous pemphigoid and intravenous gamma globulin, Ann Intern Med, 103, 965, 10.7326/0003-4819-103-6-965_1 Viero, 1986, Thrombotic thrombocytopenia and high-dose immunoglobulin treatment, Ann Intern Med, 104, 282, 10.7326/0003-4819-104-2-282_1 Fateh-Moghadam, 1982, Ein Klinisches Modellzur Regulation der humoralen Immunawort. Beitr. Infusion therapie Klin, Ernahrung, 9, 69 Gajdos, 1984, High-dose intravenous gamma globulin for myasthenia gravis, Lancet, i, 406, 10.1016/S0140-6736(84)90469-0 Fateh-Moghadam, 1984, High-dose intravenous gamma globulin for myasthenia gravis, Lancet, i, 848, 10.1016/S0140-6736(84)92294-3 Ippoliti, 1984, High-dose intravenous gamma globulin for myasthenia gravis, Lancet, ii, 809, 10.1016/S0140-6736(84)90729-3 Arsura, 1986, High-dose intravenous immunoglobulin in the management of myasthenia gravis, Arch Intern Med, 146, 1365, 10.1001/archinte.1986.00360190143020 Devathassau, 1984, High-dose gamma globulin for myasthenia gravis, Lancet ii, 809 Besinger, 1987, Immunomodulation in myasthenia gravis by high-dose intravenous 7S-immunoglobulins Lindstrom, 1976, Antibody to acetylchohne receptor in myasthenia gravis: prevalence, clinical correlates and diagnostic value, Neurology, 26, 1054, 10.1212/WNL.26.11.1054 Pascuzzi, 1984, Myasthenia gravis treatment with long-term corticosteroids; a report of 116 cases, Ann Neurol, 15, 291, 10.1002/ana.410150316 Genkins, 1976, Studies in myasthenia grauis: gamma globulins and staging Cunningham-Rundles, 1984, Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease, Ann Intern Med, 101, 435, 10.7326/0003-4819-101-4-435 Lever, 1984, Non-A non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin, Lancet, ii, 1062, 10.1016/S0140-6736(84)91506-X Webster, 1986, Non-A non-B hepatitis after intravenous gamma globulin, Lancet, i, 322, 10.1016/S0140-6736(86)90852-4 Trepo, 1986, Non-A non-B hepatitis after intravenous gamma globulin, Lancet, i, 322 Ochs, 1986, Non-A non-B hepatitis after intravenous gamma globulin, Lancet, i, 322 Bussei, 1983, Intravenous gamma globulin treatment of chronic idiopathic thrombocytopenic purpura, Blood, 62, 480, 10.1182/blood.V62.2.480.480 Ragsdale, 1980, Löss of Fc receptor activity after culture of human monocytes on surface-bound immune complexes, J Exp Med, 151, 32, 10.1084/jem.151.1.32 Bartoloni, 1981, Circulating immune complexes in myasthenia gravis: a study in relation to thymectomy, clinical severity and thymus histology, J Neurol Neuro surg Psychiatry, 44, 901, 10.1136/jnnp.44.10.901 Engel, 1979, Passively transferred experimental autoimmune myasthenia gravis. Sequential and quantitative study of endplate localization of immune complexes (IgG and C3) and of acetylchohne receptor, Neurology, 29, 179, 10.1212/WNL.29.2.179 Drachman, 1978, Myasthenia gravis (first of two parts), N Engl J Med, 298, 136, 10.1056/NEJM197801192980305 Drachman, 1978, Myasthenie antibodies cross-link acetylchohne receptors to accelerate degradation, N Engl J Med, 298, 116, 10.1056/NEJM197805182982004